TABLE 1.
Global redondovirus prevalence determined by qPCR
| Reference(s) | Country | Site | No. (%) of samples |
Condition | |
|---|---|---|---|---|---|
| Total | qPCR positive | ||||
| 2, 20 | USA | Lung, oropharynx | 69 | 6 (9) | Critical illness |
| 2, 20 | USA | Oropharynx | 60 | 9 (15) | Healthy |
| 15 | Spain | Respiratory, multiple | 100 | 2 (2) | Ill (hospital patients) |
| 4 | Italy | Respiratory, multiple | 209 | 22 (11) | Ill (hospital patients) |
| 4 | Italy | Stool | 105 | 1 (0.9) | Ill (hospital patients) |
| This study | USA | Saliva | 50 | 16 (32) | Healthy |
| This study | Botswana | Saliva | 96 | 67 (70) | Healthy |
| This study | Ethiopia | Saliva | 87 | 60 (69) | Healthy |
| This study | Tanzania | Saliva | 92 | 56 (61) | Healthy |
| This study | Cameroon | Saliva | 93 | 76 (82) | Healthy |